We are led by an experienced leadership team with a proven track record in the biopharmaceutical industry. Collectively, our leadership team has contributed to drug discovery and development as well as approval, launch and commercialization of multiple specialty medicines.

Polygon
Lynne Powell
Chief Executive Officer
Polygon
Katalin Ferenczi
General Manager, Europe
Polygon
Dr. Andreas Maetzel
Chief Medical Officer
Polygon
Dr. Roger Ilagan
Vice President of Research
Polygon
Dr. Prabo Wijetunge
Vice President Pharmaceutical Development
Polygon
Dr. Elizabeth Manning Duus
Vice President of Clinical Development
Polygon
Dr. Suzanne Thornton-Jones
Vice President, Head of Regulatory Affairs
Polygon
Sirley Steiner
Executive Director & Head of Clinical Operations
Polygon
Darren Brayton
Executive Director, Quality
Polygon
Marion McGlynn
Vice President of Project and portfolio management
Polygon
Lester Szymanik
Head of Finance